- Home
- APLM vs CELZ Comparison
APLM vs CELZ Comparison
Compare APLM & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- CELZ
- Stock Information
- Founded
- APLM 2016
- CELZ 1998
- Country
- APLM United States
- CELZ United States
- Employees
- APLM N/A
- CELZ N/A
- Industry
- APLM Blank Checks
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- APLM Finance
- CELZ Health Care
- Exchange
- APLM Nasdaq
- CELZ Nasdaq
- Market Cap
- APLM 6.5M
- CELZ 5.5M
- IPO Year
- APLM N/A
- CELZ N/A
- Fundamental
- Price
- APLM $5.68
- CELZ $1.96
- Analyst Decision
- APLM Strong Buy
- CELZ
- Analyst Count
- APLM 1
- CELZ 0
- Target Price
- APLM $200.00
- CELZ N/A
- AVG Volume (30 Days)
- APLM 25.0K
- CELZ 82.1K
- Earning Date
- APLM 04-03-2025
- CELZ 05-20-2025
- Dividend Yield
- APLM N/A
- CELZ N/A
- EPS Growth
- APLM N/A
- CELZ N/A
- EPS
- APLM N/A
- CELZ N/A
- Revenue
- APLM $198,000.00
- CELZ $11,000.00
- Revenue This Year
- APLM $415.15
- CELZ N/A
- Revenue Next Year
- APLM N/A
- CELZ N/A
- P/E Ratio
- APLM N/A
- CELZ N/A
- Revenue Growth
- APLM N/A
- CELZ 22.22
- 52 Week Low
- APLM $4.71
- CELZ $1.69
- 52 Week High
- APLM $42.00
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- APLM 40.12
- CELZ 46.43
- Support Level
- APLM $5.90
- CELZ $1.92
- Resistance Level
- APLM $6.88
- CELZ $2.12
- Average True Range (ATR)
- APLM 0.60
- CELZ 0.14
- MACD
- APLM 0.01
- CELZ 0.06
- Stochastic Oscillator
- APLM 13.17
- CELZ 88.89
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.